Sharma Priyamvada, Murthy Pratima, Bharath M M Srinivas
Centre for Addiction Medicine, Department of Psychiatry, National Institute of Mental Health & Neurosciences (NIMHANS), Bangalore, India.
Iran J Psychiatry. 2012 Fall;7(4):149-56.
Cannabis is one of the most widely abused substances throughout the world. The primary psychoactive constituent of cannabis, delta 9-tetrahydrocannabinol (▵(9_)THC), produces a myriad of pharmacological effects in animals and humans. Although it is used as a recreational drug, it can potentially lead to dependence and behavioral disturbances and its heavy use may increase the risk for psychotic disorders.Many studies that endeavor to understand the mechanism of action of cannabis concentrate on pharmacokinetics and pharmacodynamics of cannabinoids in humans. However, there is limited research on the chronic adverse effects and retention of cannabinoids in human subjects.Cannabis can be detected in body fluids following exposure through active/passive inhalation and exposure through breastfeeding. Cannabis detection is directly dependent on accurate analytical procedures for detection of metabolites and verification of recent use.In this review, an attempt has been made to summarize the properties of cannabis and its derivatives, and to discuss the implications of its use with emphasis on bioavailability, limit of detection, carry over period and passive inhalation, important factors for detection and diagnosis.
大麻是全球滥用最为广泛的物质之一。大麻的主要精神活性成分Δ⁹-四氢大麻酚(Δ⁹-THC)在动物和人类身上会产生众多药理作用。尽管它被用作消遣性毒品,但可能会导致成瘾和行为紊乱,大量使用还可能增加患精神疾病的风险。许多致力于了解大麻作用机制的研究都聚焦于大麻素在人体中的药代动力学和药效学。然而,关于大麻素在人体中的慢性不良反应和留存情况的研究却很有限。通过主动/被动吸入以及母乳喂养接触大麻后,可在体液中检测到它。大麻的检测直接依赖于用于检测代谢物和验证近期使用情况的准确分析程序。在这篇综述中,我们试图总结大麻及其衍生物的特性,并着重从生物利用度、检测限、残留期和被动吸入等对检测和诊断至关重要的因素方面,探讨其使用所带来的影响。